Journal articleClin Cancer Res2019
The sTRA Plasma Biomarker: Blinded Validation of Improved Accuracy Over CA19-9 in Pancreatic Cancer Diagnosis.
- Journal
- Clin Cancer Res
- Published
- 7 January 2019
- Citations
- 46
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 1
Grants 6
- Detection and prognosis of early-stage pancreatic cancer by interdependent plasma markers U01CA152653↗
- Targeted Glycomics and Affinity Reagents for Cancer Biomarker Development U01CA168896↗
- Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas U01CA196403↗
- Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma U01CA200466↗
- Clinical Validation Center for Early Detection of Pancreatic Cancer U01CA200468↗
- Subpopulations of Pancreatic Cancer Cells Defined by Glycan Markers U01CA226158↗